Granulomes cutanés à corps étrangers après embolisation artérielle de la sphère cervico-faciale : trois cas

Gillard, M.; Archier, E.; Monnet, O.; Souteyrand, A.; Turner, F.; Gras, Régis; Quiles‐Tsimaratos, N.

doi:10.1016/j.annder.2018.07.008

Cited by 7 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In general, control is regained over the inflammatory or autoimmune process that occurred in these patients. A similar use has been shown and a favorable outcome has been achieved with colchicine in patients with foreign body granuloma as an inflammatory tissue reaction to exogenous material (therapeutic embolization of the facial arteries), 16 or Granuloma faciale 17 and in cases of oleoma 18 (a non-allergic, foreign body type granulomatous reaction in response to oily exogenous substances injected into the dermis or subcutis for esthetical purposes).…”

Section: Clinical Cases Description: Iatrogenic Allogenosis Patients mentioning

confidence: 80%

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients

Montealegre-Gómez

Garavito

Gómez-López

et al. 2021

Reumatología Clínica

View full text Add to dashboard Cite

COVID-19 is a newly emerged disease that has become a global public health challenge. Due to a lack of knowledge about the virus, a significant number of potential targets for using a particular drug have been proposed. Five cases with a clinical history of biopolymers in the gluteal region that developed iatrogenic allogenosis (IA) are presented here. The 5 cases were put under colchicine treatment for IA crisis and had non-specific symptoms (headache, cough without dyspnea, and arthralgias) with a positive SARS-CoV-2 test. Their close contacts had mild to severe symptoms and three of them died. In the SARS-CoV-2 infection different inflammatory pathways are altered where colchicine reduces cytokine levels as well as the activation of macrophages, neutrophils, and the inflammasome. The possible mechanisms that colchicine may use to prevent acute respiratory distress syndrome (ARDS) in patients with COVID-19 infection are also reviewed in this article.

show abstract

Section: Clinical Cases Description: Iatrogenic Allogenosis Patients mentioning

confidence: 80%

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients

Montealegre-Gómez

Garavito

Gómez-López

et al. 2021

Reumatología Clínica

View full text Add to dashboard Cite

show abstract

“…In 2018, Gillard et al reported three cases of cervico‐facial cutaneous granulomatous inflammation from Embogold embolisation. Although gold was also suspected as a culprit in these cases, no patch tests were performed 12 …”

Section: Discussionmentioning

confidence: 99%

All that is gold does not glitter: Systemic allergic dermatitis and massive skin and muscle oedema following genicular artery embolisation with (Embo)gold

Mustafovski,

Stappers,

Vingerhoets

et al. 2023

Contact Dermatitis

View full text Add to dashboard Cite

Dermatopatología de la oclusión intraluminal vascular: parte II (coagulopatías, émbolos y miscelánea)

Merino

Diago

Fernández-Flores

et al. 2021

Actas Dermo-Sifiliográficas

View full text Add to dashboard Cite

Granulomes cutanés à corps étrangers après embolisation artérielle de la sphère cervico-faciale : trois cas

Cited by 7 publications

References 20 publications

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients

All that is gold does not glitter: Systemic allergic dermatitis and massive skin and muscle oedema following genicular artery embolisation with (Embo)gold

Dermatopatología de la oclusión intraluminal vascular: parte II (coagulopatías, émbolos y miscelánea)

Contact Info

Product

Resources

About